Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. (OLMA) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 202 transactions totaling $166.9M, demonstrating a bearish sentiment with -$2.3M in net insider flow. The most recent transaction on Jan 20, 2026 involved a sale of 10,000 shares valued at $268.8K.
OLMA Insider Activity Summary
Who Is Buying OLMA Stock?
No significant insider buying has been recorded for OLMA in the recent period.
Who Is Selling OLMA Stock?
No significant insider selling has been recorded for OLMA in the recent period.
Is Olema Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for OLMA is bearish with an Insider Alignment Score of 49/100 and a net flow of -$2.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
OLMA Frequently Asked Questions
Understanding OLMA Insider Activity
Insider trading at Olema Pharmaceuticals, Inc. (OLMA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading OLMA stock, having executed 202 transactions in the past 90 days. The most active insider is G. Walmsley Graham (Executive), who has made 9 transactions totaling $46.4M.
Related Tools
Track Olema Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at OLMA file new Form 4 transactions